Connexion
E-mail
Mot de passe
Afficher le mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

OXFORD BIOMEDICA PLC

(OXB)
  Rapport
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFondsCommunauté 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur OXFORD BIOMEDICA PLC
17/01Oxford Biomedica CEO Plans Exit
17/01John Dawson to retire from Oxford Biomedica
17/01Oxford Biomedica plc Announces Retirement of John Dawson as Chief Executive Officer
06/01Oxford Biomedica Signs Licence and Supply Agreement with Cabaletta Bio for LentiVector ..
05/01FTSE 100 Ends Wednesday Up Though Sentiment Is Mixed
05/01Department of Health and Social Care - One year anniversary of UK deploying Oxford-Astr..
05/01Oxford Biomedica plc - John Dawson awarded CBE in the Queen's New Year Honours List
05/01UK Grocers Gain After Upbeat Industry Sales Data
05/01FTSE 100 Falls After Mixed Trading in US, Asia
05/01Sterling Seen Having Further Room to Fight Dollar Strength
05/01Oxford Biomedica Licenses LentiVector Platform To US-based Biotechnology Group
05/01Oxford Biomedica Agroxford Biomedica Signs Licence and Supply Agreement with Cabaletta ..
04/01One year anniversary of UK deploying Oxford-AstraZeneca vaccine
2021OXFORD BIOMEDICA : Appoints Catherine Moukheibir as Non-Executive Director
2021Oxford Biomedica Signs Licence and Supply Agreement with Arcellx, Inc. for LentiVector ..
2021Oxford Biomedica updates and extends Commercial Supply Agreement for Manufacture of Len..
2021Oxford Biomedica plc Appoints Catherine Moukheibir as an Independent Non-Executive Dire..
2021Oxford Biomedica, Novartis Extend Commercial Supply Agreement For Lentiviral Vectors Un..
2021Oxford Biomedica Licenses LentiVector Platform to Arcellx
2021Oxford Biomedica plc Signs New Licence and Supply Agreement with Arcellx, Inc
2021Oxford Biomedica plc Updates and Extends Commercial Supply Agreement for Manufacture of..
2021Oxford BioMedica, Lonza, Fujifilm Eye UK's Vaccine Manufacturing Innovation Center
2021OXFORD BIOMEDICA : Boehringer Ingelheim Exercises Option
2021Oxford Biomedica Announces that Boehringer Ingelheim has Exercised Option Relating to a..
2021OXFORD BIOMEDICA : Boehringer Exercises Option To License Oxford Biomedica's Cystic Fibros..
2021Oxford Biomedica plc Announces Boehringer Ingelheim Has Exercised Option Relating to A ..
2021Is inflation still transitionary?
2021ANALYST RECOMMENDATIONS : 888, Chesapeake Energy, Conocophillips, Marathon Oil, Playtech....
2021OXFORD BIOMEDICA : Interim results for the six months ended 30 June 2021
2021OXFORD BIOMEDICA : Covid-19 vaccine maker Oxford Biomedica posts "record" revenue surge
2021FTSE : 100 gains as banks, commodity-linked stocks jump; Entain at record high
2021Oxford Biomedica Plc INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2021
2021Oxford Biomedica plc Provides Revenue Guidance for the Second Half of 2021
2021Entain Faces Uncertainty After Draftkings Offer
2021OXFORD BIOMEDICA : announces strategic investment by Serum Life Sciences Ltd
2021India's Serum Institute to invest $68 mln in UK vaccine maker Oxford Biomedica
2021FTSE 100 gains as banks, commodity-linked stocks jump; Entain at record high
2021FSE Gains, Pound's Falls May Reflect Fears of Ebbing BOE Optimism
2021OXFORD BIOMEDICA : Interim results for the six months ended 30 June 2021
2021OXFORD BIOMEDICA : Secures $68 Million Investment From Serum Institute of India Unit
2021OXFORD BIOMEDICA : Swings to H1 Profit on Revenue from COVID-19 Vaccine Manufacturing
2021OXFORD BIOMEDICA : Earnings Flash (OXB.L) OXFORD BIOMEDICA Posts H1 Revenue GBP81.3M
2021OXFORD BIOMEDICA : Earnings Flash (OXB.L) OXFORD BIOMEDICA Posts H1 EPS GBX21.36
2021Oxford Biomedica plc Reports Earnings Results for the Half Year Ended June 30, 2021
2021Oxford Biomedica plc announced that it expects to receive £50.000001 million in funding
2021FTSE 100 recovers 1% on energy, healthcare stock boost; Entain jumps
2021OXFORD BIOMEDICA : Notice of Interim Results
2021CORONAVIRUS : Uganda to benefit from UK COVID-19 vaccines donation The UK has been at the ..
2021RENEURON : To Appoint New CFO In October
2021Oxford Biomedica Appoints Michael Hayden as Non-Executive Director
2021OXFORD BIOMEDICA : Appoints Dr. Michael Hayden as Non-Executive Director
2021ASTRAZENECA : EU loses bid for speedier AstraZeneca vaccine deliveries
2021Oxford Biomedica plc Announces Retirement of Dr. Andrew Heath as Non-Executive Director
2021OXFORD BIOMEDICA : Lifts 2021 Revenue Guidance as AstraZeneca Asks for More COVID-19 Vacci..
2021FTSE 100 flat as Vodafone loss offsets gains in banks; Oxford Biomedica shines
2021ASTRAZENECA : Oxford Biomedica lifts outlook as AstraZeneca ramps up vaccine output
2021Oxford Biomedica upgrades financial guidance for supply agreement with AstraZeneca for ..
2021Oxford Biomedica plc Signs Supply Agreement with AstraZeneca UK Ltd
2021OXFORD BIOMEDICA : 2020 Annual Report and Accounts & AGM Notification
2021OXFORD BIOMEDICA : Earnings Document
2021OXFORD BIOMEDICA : Loss Shrinks As AstraZeneca Partnership Boosts Revenue
2021Oxford Biomedica plc Preliminary results for the year ended 31 December 2020
2021Oxford Biomedica plc Provides Earning Guidance for the Year 2021
2021OXFORD BIOMEDICA : Preliminary results for the year ended 31 December 2020
2021Oxford Biomedica plc Announces Andrew Heath Will Not Be Standing for Re-Election at the..
2021Oxford Biomedica plc Reports Earnings Results for the Full Year Ended December 31, 2020
2021OXFORD BIOMEDICA : Boehringer Ingelheim Enter Deal to Manufacture Viral Vectors
2021OXFORD BIOMEDICA : signs a new three year Development & Supply Agreement with Boehringer I..
2021Oxford Biomedica plc Signs Agreement with Boehringer Ingelheim
2021ASTRAZENECA : EU rebuffs UK calls to ship AstraZeneca COVID vaccines from Europe
2021SANOFI : to End Collaboration, License Deal With Oxford BioMedica
2021OXFORD BIOMEDICA : Says Sanofi to Terminate Collaboration, License Agreement
2021SANOFI : To Nix Hemophilia Collaboration With Oxford Biomedica
2021Oxford Biomedica plc Announces That Sanofi Has Given Notice That They Intend to Termina..
2021OXFORD BIOMEDICA : Open Orphan Unit Signs Contract With Oxford BioTherapeutics To Study Br..
1  2  3  4Suiv.
Prochain événement sur OXFORD BIOMEDICA PLC